Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1946 3
1949 1
1950 1
1951 5
1952 3
1953 1
1954 11
1955 10
1956 34
1957 59
1958 49
1959 67
1960 36
1961 47
1962 21
1963 29
1964 73
1965 55
1966 73
1967 67
1968 90
1969 81
1970 101
1971 80
1972 105
1973 91
1974 101
1975 138
1976 113
1977 131
1978 116
1979 103
1980 108
1981 124
1982 114
1983 139
1984 162
1985 141
1986 167
1987 156
1988 131
1989 172
1990 185
1991 176
1992 204
1993 187
1994 205
1995 204
1996 252
1997 260
1998 284
1999 272
2000 326
2001 368
2002 374
2003 342
2004 446
2005 516
2006 468
2007 443
2008 467
2009 499
2010 504
2011 506
2012 522
2013 560
2014 563
2015 575
2016 556
2017 544
2018 521
2019 516
2020 532
2021 541
2022 539
2023 59
Text availability
Article attribute
Article type
Publication date

Search Results

15,716 results
Results by year
Filters applied: . Clear all The following term was ignored: "
Page 1
Evaluating off-label uses of acetazolamide.
Van Berkel MA, Elefritz JL. Van Berkel MA, et al. Am J Health Syst Pharm. 2018 Apr 15;75(8):524-531. doi: 10.2146/ajhp170279. Am J Health Syst Pharm. 2018. PMID: 29626002 Review.
PURPOSE: Current off-label uses of acetazolamide in hospitalized patients are reviewed. SUMMARY: Acetazolamide is a carbonic anhydrase inhibitor typically used for indications including epilepsy, glaucoma, edema, and altitude sickness but it may be pre …
PURPOSE: Current off-label uses of acetazolamide in hospitalized patients are reviewed. SUMMARY: Acetazolamide is a carboni
Benzyl alcohol inhibits carbonic anhydrases by anchoring to the zinc coordinated water molecule.
De Simone G, Bua S, Supuran CT, Alterio V. De Simone G, et al. Biochem Biophys Res Commun. 2021 Apr 9;548:217-221. doi: 10.1016/j.bbrc.2021.02.067. Epub 2021 Feb 27. Biochem Biophys Res Commun. 2021. PMID: 33647799
Up to date alcohols have been scarcely investigated as carbonic anhydrase (CA) inhibitors. To get more insights into the CA inhibition properties of this class of molecules, in this paper, by means of inhibition assays and X-ray crystallo …
Up to date alcohols have been scarcely investigated as carbonic anhydrase (CA) inhibitors. To get more insights into the CA …
Carbonic anhydrase inhibition and the management of neuropathic pain.
Supuran CT. Supuran CT. Expert Rev Neurother. 2016 Aug;16(8):961-8. doi: 10.1080/14737175.2016.1193009. Epub 2016 Jun 2. Expert Rev Neurother. 2016. PMID: 27211329 Review.
AREAS COVERED: Recent advances in understanding the pathological mechanisms of this syndrome and the biochemical/pharmacological characterization of novel drug targets, evidenced carbonic anhydrase (CA, EC 4.2.1.1) inhibition as a new approach for desi …
AREAS COVERED: Recent advances in understanding the pathological mechanisms of this syndrome and the biochemical/pharmacological characteriz …
Acetazolamide: a forgotten diuretic agent.
Kassamali R, Sica DA. Kassamali R, et al. Cardiol Rev. 2011 Nov-Dec;19(6):276-8. doi: 10.1097/CRD.0b013e31822b4939. Cardiol Rev. 2011. PMID: 21983315 Review.
Acetazolamide is the only carbonic anhydrase inhibitor with significant diuretic effects. ...Its administration is ordinarily marked by a brisk alkaline diuresis. Although carbonic anhydrase inhibitors are proximal tubular diuretics (where the b
Acetazolamide is the only carbonic anhydrase inhibitor with significant diuretic effects. ...Its administration is ordi
Acetazolamide for the treatment of idiopathic intracranial hypertension.
Supuran CT. Supuran CT. Expert Rev Neurother. 2015;15(8):851-6. doi: 10.1586/14737175.2015.1066675. Epub 2015 Jul 7. Expert Rev Neurother. 2015. PMID: 26154918 Review.
Idiopathic intracranial hypertension (IIH) is characterized by an increase of intracranial pressure in the absence of neurologic tumors. The sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor (CAI) acetazolamide (AAZ), a compound developed in th …
Idiopathic intracranial hypertension (IIH) is characterized by an increase of intracranial pressure in the absence of neurologic tumors. The …
Acetazolamide in the treatment of seizures.
Reiss WG, Oles KS. Reiss WG, et al. Ann Pharmacother. 1996 May;30(5):514-9. doi: 10.1177/106002809603000515. Ann Pharmacother. 1996. PMID: 8740334 Review.
OBJECTIVE: To summarize the pharmacology, pharmacokinetics, efficacy, and safety of acetazolamide and to evaluate its therapeutic role in patients with epilepsy. ...DATA SYNTHESIS: Acetazolamide, a carbonic anhydrase inhibitor, has been approved …
OBJECTIVE: To summarize the pharmacology, pharmacokinetics, efficacy, and safety of acetazolamide and to evaluate its therapeu …
ANTICONVULSANT DRUGS.
SPINKS A, WARING WS. SPINKS A, et al. Prog Med Chem. 1963;19:261-331. doi: 10.1016/s0079-6468(08)70120-6. Prog Med Chem. 1963. PMID: 14146302 Review. No abstract available.
[Acetazolamide].
Walstad RA. Walstad RA. Tidsskr Nor Laegeforen. 1990 Apr 30;110(11):1376-7. Tidsskr Nor Laegeforen. 1990. PMID: 2339384 Norwegian. No abstract available.
Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice.
Gulati S, Aref AA. Gulati S, et al. Expert Rev Clin Pharmacol. 2021 Aug;14(8):955-961. doi: 10.1080/17512433.2021.1931123. Epub 2021 May 25. Expert Rev Clin Pharmacol. 2021. PMID: 34003717 Review.
Introduction: Systemic acetazolamide is an efficacious adjunct to topical therapy to lower intraocular pressure (IOP) in glaucomatous eyes. ...Though not often a first-line option, oral carbonic anhydrase inhibitors remain pivotal and play in important role i …
Introduction: Systemic acetazolamide is an efficacious adjunct to topical therapy to lower intraocular pressure (IOP) in glaucomatous …
The effect of acetazolamide and carbonic anhydrase inhibition on erythrocyte 2,3-diphosphoglycerate content and metabolism.
Rolf LL Jr, Garg LC. Rolf LL Jr, et al. J Pharmacol Exp Ther. 1975 May;193(2):639-46. J Pharmacol Exp Ther. 1975. PMID: 1142109
Experiments were designed to test the hypothesis that the change in erythrocyte 2,3-diphosphoglycerate (2,3-DPG) content which occurs when metabolic acidosis is induced by prolonged inhibition of carbonic anhydrase in vivo is the same as that wh …
Experiments were designed to test the hypothesis that the change in erythrocyte 2,3-diphosphoglycerate (2,3-DPG) content which …
15,716 results
You have reached the last available page of results. Please see the User Guide for more information.